These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1268432)

  • 1. Proposed current good manufacturing practice and supplemental regulations.
    Korun FD
    Bull Parenter Drug Assoc; 1976; 30(3):139-42. PubMed ID: 1268432
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view.
    Fink JL
    Contemp Pharm Pract; 1979; 2(4):202-5. PubMed ID: 10244540
    [No Abstract]   [Full Text] [Related]  

  • 3. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 4. A summarized discussion of current good manufacturing practice regulations.
    Allen LV
    Int J Pharm Compd; 2013; 17(3):210-9. PubMed ID: 24046937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current good manufacturing practice regulations.
    Bumiller J
    Bull Parenter Drug Assoc; 1971; 25(5):222-5. PubMed ID: 5094094
    [No Abstract]   [Full Text] [Related]  

  • 6. Current good manufacturing practices for PET drug products in the United States.
    Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
    J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
    [No Abstract]   [Full Text] [Related]  

  • 7. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When does compounding become manufacturing?
    Gushee J
    J Am Vet Med Assoc; 1994 Jul; 205(2):235-6. PubMed ID: 7928585
    [No Abstract]   [Full Text] [Related]  

  • 9. [Maintaining standards of good compounding (N.B.F.)].
    Castoldi B; Fumagalli A; Mazzoldi G
    Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351
    [No Abstract]   [Full Text] [Related]  

  • 10. Disinfectants as an aid for good manufacturing practice in the pharmaceutical industry.
    Wallhäusser KH
    J Pharm Belg; 1981; 36(5):283-97. PubMed ID: 7310623
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medicines raw materials used in compounding medicines: an update of the legislation].
    Huyghebaert C; Leuckx S
    J Pharm Belg; 2010 Mar; (1):16-8. PubMed ID: 20429391
    [No Abstract]   [Full Text] [Related]  

  • 12. Formulation/manufacturing: a basic bibliography (#51).
    Moores KG; Lange PG
    Hosp Pharm; 1988 Nov; 23(11):1039. PubMed ID: 10302983
    [No Abstract]   [Full Text] [Related]  

  • 13. I. Federal regulations concerning use of asbestos filters in manufacturing parenteral drugs.
    Casola AR
    Bull Parenter Drug Assoc; 1975; 29(5):216-8. PubMed ID: 1182330
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical controls for drug availability.
    Bethel RF
    Med Serv J Can; 1967 Mar; 23(3):337-45. PubMed ID: 6061040
    [No Abstract]   [Full Text] [Related]  

  • 15. Responsible drug compounding in small animal practice.
    Reid JS
    J Am Vet Med Assoc; 1994 Jul; 205(2):204-6. PubMed ID: 7928576
    [No Abstract]   [Full Text] [Related]  

  • 16. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral manufacturing and legal regulations.
    Tamura LK
    Bull Parenter Drug Assoc; 1968; 22(6):261-6. PubMed ID: 5727161
    [No Abstract]   [Full Text] [Related]  

  • 18. Proposed rule: current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements.
    Melethil S
    Life Sci; 2006 Mar; 78(18):2049-53. PubMed ID: 16516243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems associated with veterinary compounding in swine practice.
    McKean JD
    J Am Vet Med Assoc; 1994 Jul; 205(2):279-83. PubMed ID: 7928598
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.